Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?

Are there differences in efficacy and safety between local and imported direct-acting antiviral agents for hepatitis C in China?

Abstract Background Despite price advantages, local direct-acting antiviral agents (DAAs) for hepatitis C (hep C) have not been widely used in China compared with the imported ones. There is no evidence on their relative efficacy and safety, nor whether the small market share of local DAAs was attri...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhitao Wang, Youbing Ran, Yihan Fu, Jing Sun, Yuanli Liu
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Infectious Diseases of Poverty
Subjects:
Direct-acting antiviral agent
Hepatitis C
Hepatitis C virus
Efficacy
Safety
Online Access:https://doi.org/10.1186/s40249-025-01344-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items